Abstract:During infectious disease outbreaks, humans often base their decision to adhere to an intervention strategy on their personal opinion towards the intervention, perceived risk of infection and intervention effectiveness. However, due to data limitations and inference challenges, infectious disease models usually omit variables that may impact an individual's decision to get vaccinated and their awareness of the intervention's effectiveness of disease control within their social contacts as well as the overall population. We constructed a compartmental, deterministic Susceptible-Exposed-Infectious-Recovered (SEIR) disease model that includes a behavioural function with parameters influencing intervention uptake. The behavioural function accounted for an initial subpopulation opinion towards an intervention, their outbreak information awareness sensitivity and the extent they are swayed by the real-time intervention effectiveness information (at a subpopulation- and population-level) — the selected real-time response construct mimicked a situation of reductions in vaccine uptake due to a negative behavioural response arising from imperfect vaccine protection resulting in breakthrough infections and deaths in vaccinated individuals. Applying the model to vaccination uptake and three human pathogens — pandemic influenza, SARS-CoV-2 and Ebola virus — we explored through model simulation how these intervention adherence decision parameters and behavioural heterogeneity in the population impacted epidemiological outcomes. From our model simulations we found that differences in preference towards outbreak information were pathogen-specific. In other words, in some pathogen systems, different types of outbreak information awareness at different outbreak stages may be more informative to an information-sensitive population and lead to less severe epidemic outcomes. In both behaviourally-homogeneous and behaviourally-heterogeneous populations, pandemic influenza showed patterns distinct from SARS-CoV-2 and Ebola for cumulative epidemiological metrics of interest. Furthermore, there was notable sensitivity in outbreak size under different assumptions regarding the population split in behavioural traits. Outbreak information preference was sensitive to vaccine efficacy, which demonstrates the importance of considering human behaviour during outbreaks in the context of the perceived effectiveness of the intervention. Incorporating behavioural functions that modify infection control intervention adherence into epidemiological models can aid our understanding of adherence dynamics during outbreaks. Ultimately, by parameterising models with what we know about human behaviour towards vaccination (and other infection control interventions) adherence, such models can help assist decision makers during outbreaks. Such progress will be particularly important for emerging infectious diseases when there is initially little information on the disease dynamics and intervention effectiveness.

Modelling infectious disease to support human health

Animal and translational models of SARS-CoV-2 infection and COVID-19

The value of infectious disease modeling and trend assessment: a public health perspective

Mechanistic Models of COVID-19: Insights into Disease Progression, Vaccines, and Therapeutics

Advances and gaps in SARS-CoV-2 infection models

Modeling infectious disease dynamics in the complex landscape of global health

Recent Advances of COVID-19 Modeling Based on Regenerative Medicine

The modelling of COVID19 pathways sheds light on mechanisms, opportunities and on controversial interpretations of medical treatments. v2

A systems approach to infectious disease

Infectious Diseases: Considerations for the 21st Century

Unifying human infectious disease models and real-time awareness of population- and subpopulation-level intervention effectiveness

Rapid Development of Small Rodent Animal Models for Infectious Disease Research Through Vectorized Receptor Molecule Expression

Cell and animal models of SARS-CoV-2 pathogenesis and immunity

Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control

Recent approaches in computational modelling for controlling pathogen threats

Animal models for COVID-19: advances, gaps and perspectives

Building a Resilient Scientific Network for COVID-19 and Beyond

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges

Modelling: Understanding pandemics and how to control them

Best practice assessment of disease modelling for infectious disease outbreaks

Addressing the Threat of Emerging Viral Infections